Athersys, Biotech Stock Review

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one...
Internet Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value & Stand Down VIII:

Bear Comments from Roubini, Jim Chanos, Jim Rogers and James A. Kostohryz Don't Be That Guy in Denial!
Biotech Stock Review, Novellus, Citius

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.

Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.

‘Early Detection, Early Response.’ How Smallpox Which Killed 300 Million, Was Eradicated.

During the 20th century, it is estimated that smallpox was responsible for 300–500 million deaths. In the early 1950s, an estimated 50...
Biotech Stock Review

Regular Old Flu, Kills 290,000 to 650,000 a Year.

Be Careful of the Regular Flu. Not in any way to downplay Corona's deadly path - but even...

Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.

Companies With 'CoronaVirus' in Their Press Release Today: Waitr (WTRH) up 86% - Online Food Ordering for Quarantined...
Aphex BioCleanse

Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.

Former Eastman Kodak Scientist and Engineers Develop Liquid Germ Killer Hy-IQ® to Revolutionize the way Deadly Bacteria and Virus are Eradicated

Latest article

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...